MLL rearrangements are detected in over 70% of all infant leukemias and in 5–10% of childhood and adult ALL or AML cases; they are also a common cause of chemotherapy related secondary leukemias ([120] and reviewed in [121,122]). This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.